Novavax is trading 5.5% lower at $10.40 as of 11:12 a.m. EDT on October 22, 2026, amid broad risk-off pressure. - No clear company-specific catalyst for the decline was identified in available coverage. - Reuters reported renewed pressure on growth stocks and higher oil prices; reports of tanker damage in the Strait of Hormuz weighed on markets. - The broader market, including the Nasdaq, was sharply lower, making global sentiment the likeliest explanation rather than a confirmed Novavax-specific event.